05/08/2024 8:21 PM | Innoviva (Filer)
| Form ARS | |
05/08/2024 3:44 PM | Innoviva (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/08/2024 3:46 PM | Innoviva (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/08/2024 2:38 PM | FRANKLIN RESOURCES INC (Filed by) Innoviva (Subject)
| Form SC 13D | |
05/01/2024 5:07 PM | Innoviva (Issuer) Small Derek A (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
04/29/2024 4:30 PM | Innoviva (Filer)
| Form DEFA14A | |
04/29/2024 4:25 PM | Innoviva (Filer)
| Form DEF 14A | |
|
03/07/2024 5:57 PM | Innoviva (Issuer) Raifeld Pavel (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2024 6:00 PM | Innoviva (Issuer) Zhen Marianne (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2024 6:02 PM | Innoviva (Issuer) Ronsheim Matthew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2024 6:04 PM | Basso Stephen (Reporting) Innoviva (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 4:35 PM | Armata Pharmaceuticals, Inc. (Subject) Innoviva (Filed by)
| Form SC 13D/A | |
02/29/2024 4:01 PM | Innoviva (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/22/2024 8:30 PM | Innoviva (Issuer) Zhen Marianne (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/22/2024 8:31 PM | Innoviva (Issuer) Ronsheim Matthew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 6:23 AM | Innoviva (Subject) PUTNAM INVESTMENTS LLC (Filed by)
| Form SC 13G/A | |
02/13/2024 9:26 AM | Innoviva (Subject) RENAISSANCE TECHNOLOGIES LLC (Filed by)
| Form SC 13G/A | |
01/22/2024 8:16 PM | Innoviva (Issuer) Ronsheim Matthew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/22/2024 1:03 PM | BlackRock Inc. (Filed by) Innoviva (Subject)
| Form SC 13G/A | |
01/10/2024 7:26 PM | Innoviva (Issuer) Ronsheim Matthew (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
11/22/2023 3:30 PM | Innoviva (Issuer) Zhen Marianne (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/17/2023 3:30 PM | Innoviva (Issuer) Zhen Marianne (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/06/2023 7:30 AM | Innoviva (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/01/2023 3:44 PM | Innoviva (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/01/2023 3:30 PM | Innoviva (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/31/2023 7:10 PM | Basso Stephen (Reporting) Innoviva (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
08/31/2023 7:12 PM | Basso Stephen (Reporting) Innoviva (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/25/2023 4:24 PM | Innoviva (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/02/2023 8:31 PM | Innoviva (Issuer) Koziel Margaret (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
08/02/2023 8:32 PM | Innoviva (Issuer) Koziel Margaret (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/11/2023 7:27 AM | Armata Pharmaceuticals, Inc. (Subject) Innoviva (Filed by)
| Form SC 13D/A | |
07/11/2023 7:16 AM | Innoviva (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/20/2023 8:00 PM | DENNER ALEXANDER J (Reporting) Innoviva (Issuer) Sarissa Capital Management LP (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2023 7:10 PM | DENNER ALEXANDER J (Reporting) Innoviva (Issuer) Sarissa Capital Management LP (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/30/2023 6:01 PM | DENNER ALEXANDER J (Reporting) Innoviva (Issuer) Sarissa Capital Management LP (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/24/2023 4:56 PM | Birx Deborah (Reporting) Innoviva (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/24/2023 4:57 PM | Innoviva (Issuer) Srivastava Sapna (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/24/2023 4:47 PM | Innoviva (Issuer) Odysseas Kostas D (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/24/2023 4:50 PM | DiPaolo Mark (Reporting) Innoviva (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/24/2023 4:53 PM | Haimovitz Jules (Reporting) Innoviva (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/24/2023 4:54 PM | Innoviva (Issuer) Schlesinger Sarah J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
Bill Clinton Backing Biden Replacement??? (Ad) Bill Clinton is back.
And he just met in Mexico with the one person I believe could REPLACE Joe Biden by August… Click here now for my urgent election forecast. |
05/24/2023 4:18 PM | Innoviva (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/23/2023 3:30 PM | Innoviva (Issuer) Zhen Marianne (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/19/2023 8:12 PM | DENNER ALEXANDER J (Reporting) Innoviva (Issuer) Sarissa Capital Management LP (Reporting)
| Form 4/A | |
05/19/2023 7:00 PM | DENNER ALEXANDER J (Reporting) Innoviva (Issuer) Sarissa Capital Management LP (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/17/2023 4:18 PM | Innoviva (Filer)
| Form DEFA14A | |
05/15/2023 8:05 PM | DENNER ALEXANDER J (Reporting) Innoviva (Issuer) Sarissa Capital Management LP (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
05/15/2023 8:09 PM | DENNER ALEXANDER J (Reporting) Innoviva (Issuer) Sarissa Capital Management LP (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |